BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Institute for Bioengineering of Catalonia - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Institute for Bioengineering of Catalonia
X-ORIGINAL-URL:https://ibecbarcelona.eu/es/
X-WR-CALDESC:Eventos para Institute for Bioengineering of Catalonia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20160327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20161030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20171029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20170427T120000
DTEND;TZID=Europe/Madrid:20170427T130000
DTSTAMP:20260429T035936
CREATED:20170403T100450Z
LAST-MODIFIED:20170801T105124Z
UID:28814-1493294400-1493298000@ibecbarcelona.eu
SUMMARY:IBEC-IRB Barcelona joint seminar: Erik Sahai
DESCRIPTION:Imaging therapy response and failure\nErik Sahai\, The Francis Crick Institute\, London\nMany tumors show an initial response to targeted therapies before genetic resistance emerges\, however little is known about how tumor cells tolerate therapy before genetic resistance dominates. We present data that shows how the ECM generates a ‘safe haven’ in which melanoma cells can tolerate targeted therapy.  This supports the population of cancer cells from which genetically resistance emerges. We are now studying the emergence of resistant clones and clonal competition in the context of ‘safe havens’. Finally\, we present analysis of organ specific responses to targeted therapy in melanoma.
URL:https://ibecbarcelona.eu/es/event/ibec-irb-barcelona-joint-seminar-erik-sahai/
LOCATION:Sala Félix Serratossa\, Parc Científic de Barcelona\, Barcelona\, Spain
CATEGORIES:Joint seminar / workshop / symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20170427T120000
DTEND;TZID=Europe/Madrid:20170427T130000
DTSTAMP:20260429T035936
CREATED:20170403T100450Z
LAST-MODIFIED:20170403T100450Z
UID:96031-1493294400-1493298000@ibecbarcelona.eu
SUMMARY:IBEC-IRB Barcelona joint seminar: Erik Sahai
DESCRIPTION:Imaging therapy response and failure\nErik Sahai\, The Francis Crick Institute\, London\nMany tumors show an initial response to targeted therapies before genetic resistance emerges\, however little is known about how tumor cells tolerate therapy before genetic resistance dominates. We present data that shows how the ECM generates a ‘safe haven’ in which melanoma cells can tolerate targeted therapy.  This supports the population of cancer cells from which genetically resistance emerges. We are now studying the emergence of resistant clones and clonal competition in the context of ‘safe havens’. Finally\, we present analysis of organ specific responses to targeted therapy in melanoma.
URL:https://ibecbarcelona.eu/es/event/ibec-irb-barcelona-joint-seminar-erik-sahai-3/
LOCATION:Sala Félix Serratossa\, Parc Científic de Barcelona\, Barcelona\, Spain
CATEGORIES:Joint seminar / workshop / symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20170427T120000
DTEND;TZID=Europe/Madrid:20170427T130000
DTSTAMP:20260429T035936
CREATED:20170403T100450Z
LAST-MODIFIED:20170403T100450Z
UID:96030-1493294400-1493298000@ibecbarcelona.eu
SUMMARY:IBEC-IRB Barcelona joint seminar: Erik Sahai
DESCRIPTION:Imaging therapy response and failure\nErik Sahai\, The Francis Crick Institute\, London\nMany tumors show an initial response to targeted therapies before genetic resistance emerges\, however little is known about how tumor cells tolerate therapy before genetic resistance dominates. We present data that shows how the ECM generates a ‘safe haven’ in which melanoma cells can tolerate targeted therapy.  This supports the population of cancer cells from which genetically resistance emerges. We are now studying the emergence of resistant clones and clonal competition in the context of ‘safe havens’. Finally\, we present analysis of organ specific responses to targeted therapy in melanoma.
URL:https://ibecbarcelona.eu/es/event/ibec-irb-barcelona-joint-seminar-erik-sahai-2/
LOCATION:Sala Félix Serratossa\, Parc Científic de Barcelona\, Barcelona\, Spain
CATEGORIES:Joint seminar / workshop / symposium
END:VEVENT
END:VCALENDAR